CN Stock MarketDetailed Quotes

300086 Honz Pharmaceutical

Watchlist
  • 4.94
  • +0.62+14.35%
Market Closed Sep 30 15:00 CST
2.22BMarket Cap-21021P/E (TTM)

Honz Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-41.29%100.73M
-36.34%114.29M
-46.48%144.4M
-42.03%104.64M
20.35%171.58M
12.61%179.52M
4.35%269.81M
-40.99%180.51M
-25.71%142.57M
-25.66%159.41M
Notes receivable and accounts receivable
16.52%70.37M
94.07%109.66M
90.91%139.63M
-51.05%45.98M
-37.21%60.39M
-54.67%56.5M
-52.24%73.14M
27.70%93.94M
-4.92%96.18M
-1.53%124.65M
-Notes receivable
-31.21%6.04M
39.85%8.96M
87.04%3.76M
-96.40%318.63K
210.13%8.78M
8.92%6.41M
-46.61%2.01M
46.55%8.84M
2.58%2.83M
1,565.61%5.88M
-Accounts receivable
24.63%64.33M
101.01%100.69M
91.02%135.87M
-46.34%45.66M
-44.71%51.61M
-57.82%50.09M
-52.39%71.13M
26.01%85.09M
-5.13%93.35M
-5.91%118.77M
Other receivables (including interest and dividends)
0.94%57.84M
-6.27%63.56M
-18.00%55.46M
130.58%65.9M
-28.94%57.31M
-23.35%67.81M
-22.76%67.64M
-66.17%28.58M
71.07%80.64M
100.61%88.46M
-Other receivable
0.94%57.84M
----
-18.00%55.46M
----
-28.94%57.31M
----
-22.76%67.64M
----
71.07%80.64M
----
Advance payment
-12.65%34.84M
-3.23%37.63M
-68.32%28.1M
57.94%37.39M
79.09%39.88M
24.77%38.89M
315.00%88.7M
-8.77%23.68M
-27.63%22.27M
-10.42%31.16M
Inventories
-1.15%245.22M
8.16%240.87M
38.75%236.43M
50.71%264.13M
38.79%248.07M
15.32%222.69M
-13.88%170.4M
-19.71%175.25M
-18.98%178.74M
-8.75%193.11M
Other current assets
133.24%6.23M
-1.91%3.05M
593.00%5.33M
1,120.49%7.72M
653.91%2.67M
217.72%3.11M
-44.34%768.88K
-84.13%632.78K
-95.09%354.14K
-81.47%979.19K
Total current assets
-11.15%515.22M
0.09%569.05M
-9.11%609.35M
4.61%525.77M
11.36%579.91M
-4.90%568.52M
-6.87%670.46M
-29.43%502.58M
-14.04%520.75M
-6.13%597.79M
Non Current assets
Other equity investment
-10.87%5.3M
-10.87%5.3M
-10.87%5.3M
-3.91%5.95M
-3.91%5.95M
-3.91%5.95M
-3.91%5.95M
11.47%6.19M
11.47%6.19M
11.47%6.19M
Investment real estate
-4.88%226.01M
-4.88%226.01M
-4.88%226.01M
-8.25%237.61M
-8.25%237.61M
-8.25%237.61M
-6.07%237.61M
3.76%258.98M
3.76%258.98M
3.76%258.98M
Long-term equity investment
----
----
----
----
----
----
----
-66.36%4.63M
-66.31%4.68M
-66.17%4.73M
Fixed assets
-1.81%847.79M
----
-5.53%841.67M
----
156.97%863.42M
----
169.49%890.94M
----
4.91%335.99M
----
Fixed assets liquidation
--27.9K
----
--27.9K
----
----
----
----
----
----
----
Constru in process
63.55%146.29M
----
144.37%145.62M
----
-86.95%89.44M
----
-90.96%59.59M
----
13.89%685.27M
----
Productive biological assets
--17.16K
----
----
----
----
----
----
----
----
----
Intangible assets
-3.20%157.84M
-4.36%158.06M
-4.31%160.33M
-17.36%161.08M
-17.45%163.06M
-17.42%165.26M
-17.33%167.55M
3.67%194.91M
22.50%197.52M
23.18%200.13M
Development expenditure
22.86%46.86M
14.50%43.67M
16.85%43.64M
0.80%38.14M
0.80%38.14M
0.80%38.14M
-1.29%37.35M
16.51%37.83M
16.51%37.83M
16.85%37.83M
Goodwill
9.19%20.63M
6.14%20.05M
6.14%20.05M
0.00%18.89M
0.00%18.89M
0.00%18.89M
0.00%18.89M
-15.25%18.89M
-93.88%18.89M
-93.88%18.89M
Long deferred expense
-13.87%32.35M
-1.96%38.03M
-1.26%37.38M
4.78%35.65M
20.28%37.56M
16.88%38.79M
8.10%37.86M
-5.10%34.02M
-22.77%31.23M
-14.12%33.19M
Deferred tax assets
17.97%58.04M
-8.96%43.37M
-11.70%42.3M
48.82%43.78M
83.35%49.2M
70.55%47.64M
84.71%47.9M
12.01%29.42M
-7.13%26.83M
-13.13%27.93M
Other non current assets
-52.19%29.61M
-37.08%57.09M
-70.32%33.95M
-69.03%38.88M
-53.27%61.93M
-47.49%90.73M
-30.56%114.37M
-29.12%125.56M
-30.12%132.52M
3.40%172.76M
Total non current assets
0.36%1.57B
-1.16%1.56B
-3.82%1.56B
-9.23%1.56B
-9.84%1.57B
-10.28%1.58B
-6.95%1.62B
2.13%1.72B
-12.09%1.74B
-8.24%1.76B
Total assets
-2.76%2.09B
-0.83%2.13B
-5.37%2.17B
-6.10%2.09B
-4.94%2.15B
-8.91%2.15B
-6.93%2.29B
-7.24%2.22B
-12.54%2.26B
-7.71%2.36B
Liabilities
Current liabilities
Short term loan
66.20%174.51M
60.77%169.8M
5.01%139.89M
17.29%84M
-12.15%105M
-27.28%105.62M
-10.29%133.22M
-63.45%71.62M
-53.94%119.52M
-33.86%145.25M
Notes payable and accounts payable
-27.92%75.56M
9.11%63.82M
35.92%78.02M
48.21%99.85M
25.35%104.83M
-39.46%58.49M
-48.90%57.4M
-42.15%67.37M
-39.33%83.63M
-19.32%96.61M
-Notes payable
-85.55%5.78M
----
----
--40M
--40M
----
----
----
----
----
-Accounts payable
7.64%69.78M
9.11%63.82M
35.92%78.02M
-11.17%59.85M
-22.48%64.83M
-39.46%58.49M
-48.90%57.4M
-42.15%67.37M
-39.33%83.63M
-19.32%96.61M
Contract liabilities
42.52%25.43M
-39.57%14.42M
-88.72%10.79M
33.37%13.99M
31.20%17.85M
61.50%23.87M
266.55%95.66M
-3.43%10.49M
-51.63%13.6M
-46.31%14.78M
Advance receipts
797.87%240K
48.01%12.3K
-33.33%7.78K
--21.15K
--26.73K
--8.31K
--11.68K
----
----
----
Salaries payable
-4.72%8.17M
-18.50%8.66M
0.16%11.09M
-3.93%8.78M
-1.37%8.58M
25.59%10.62M
12.27%11.07M
12.65%9.14M
-36.27%8.7M
-35.04%8.46M
Taxs payable
-34.08%9.85M
80.74%24.81M
28.85%32.2M
12.40%16.71M
-29.43%14.95M
-17.24%13.73M
-2.45%24.99M
26.82%14.86M
55.19%21.18M
35.95%16.59M
Other payable (including interest and dividends)
23.64%74.72M
0.40%70.18M
-1.30%70.44M
13.12%62.31M
5.07%60.44M
20.59%69.9M
17.92%71.36M
-19.35%55.08M
-33.83%57.52M
-27.53%57.97M
-Interest payable
----
----
----
----
----
--640.69K
----
----
----
----
-Other payable
23.64%74.72M
----
-1.30%70.44M
----
5.07%60.44M
----
17.92%71.36M
----
-26.19%57.52M
----
Non current liabilities due within one year
8.94%75.94M
-56.51%37.62M
-65.65%36.77M
-26.75%69.71M
-29.38%69.71M
-11.14%86.51M
6.22%107.05M
215.26%95.17M
234.81%98.72M
381.61%97.35M
Other current liabilities
38.12%3.19M
-43.20%1.76M
-63.05%1.38M
32.89%1.81M
30.78%2.31M
61.40%3.1M
207.04%3.74M
-33.96%1.36M
0.04%1.77M
36.90%1.92M
Total current liabilities
16.67%447.63M
5.17%391.09M
-24.56%380.59M
9.87%357.18M
-5.18%383.69M
-15.28%371.85M
4.04%504.51M
-26.73%325.1M
-29.12%404.63M
-11.10%438.93M
Current liabilities
Long term loan
-12.91%267.06M
-0.09%322.05M
-5.21%324.98M
-16.15%305.14M
-1.08%306.64M
-4.46%322.33M
-0.20%342.85M
-1.97%363.9M
-21.62%310M
-12.26%337.37M
Deferred tax liabilities
-4.69%33.33M
-2.15%34.04M
-2.16%33.86M
-15.56%35.15M
-15.63%34.97M
-15.70%34.79M
-15.79%34.6M
1.57%41.63M
-2.19%41.45M
-1.99%41.27M
Long term deferred income
3.14%51.13M
-5.56%47.49M
-5.54%48.18M
-5.03%48.87M
35.05%49.57M
42.01%50.29M
43.23%51M
43.72%51.46M
1.74%36.71M
-2.72%35.41M
Total non current liabilities
-10.14%351.52M
-0.94%403.58M
-5.00%407.01M
-14.84%389.16M
0.78%391.18M
-1.61%407.4M
1.96%428.45M
1.09%456.99M
-20.48%388.16M
-15.68%414.05M
Total liabilities
3.13%799.15M
1.98%794.66M
-15.58%787.6M
-4.57%746.34M
-2.26%774.87M
-8.64%779.25M
3.07%932.96M
-12.69%782.09M
-25.14%792.79M
-13.38%852.98M
Shareholders equity
Paid-in capital
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
3.43%847.08M
2.86%842.36M
2.14%836.49M
1.07%827.73M
0.00%818.96M
0.00%818.96M
0.00%818.96M
-0.12%818.96M
-0.12%818.96M
-0.12%818.96M
Surplus reserve funds
4.00%54.94M
4.00%54.94M
4.00%54.94M
0.00%52.83M
0.00%52.83M
0.00%52.83M
0.00%52.83M
10.80%52.83M
10.80%52.83M
10.80%52.83M
Retained profit
-258.03%-149.52M
-123.08%-95.16M
16.21%-48.66M
-494.57%-78.53M
-200.05%-41.76M
-151.23%-42.66M
-144.84%-58.07M
-75.75%19.9M
-36.79%41.74M
-18.99%83.27M
Other composite income
-0.92%51.98M
-0.92%51.98M
-0.92%51.98M
-0.34%52.47M
-0.34%52.47M
-0.34%52.47M
-0.34%52.47M
0.92%52.65M
0.92%52.65M
0.92%52.65M
Shareholders equity without minority interests
-5.85%1.25B
-2.06%1.3B
2.17%1.34B
-6.44%1.3B
-5.91%1.33B
-8.65%1.33B
-12.48%1.32B
-3.96%1.39B
-1.37%1.42B
-1.01%1.46B
Minority interests
-14.28%32.35M
-15.06%32.44M
-15.41%33.26M
-21.33%36.83M
-20.92%37.74M
-21.45%38.19M
-20.86%39.33M
-5.02%46.81M
-44.20%47.72M
-50.97%48.61M
Total shareholder equity
-6.09%1.29B
-2.43%1.34B
1.66%1.38B
-6.93%1.34B
-6.40%1.37B
-9.06%1.37B
-12.75%1.36B
-4.00%1.44B
-3.78%1.46B
-4.16%1.51B
Total liabilityies and equity
-2.76%2.09B
-0.83%2.13B
-5.37%2.17B
-6.10%2.09B
-4.94%2.15B
-8.91%2.15B
-6.93%2.29B
-7.24%2.22B
-12.54%2.26B
-7.71%2.36B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -41.29%100.73M-36.34%114.29M-46.48%144.4M-42.03%104.64M20.35%171.58M12.61%179.52M4.35%269.81M-40.99%180.51M-25.71%142.57M-25.66%159.41M
Notes receivable and accounts receivable 16.52%70.37M94.07%109.66M90.91%139.63M-51.05%45.98M-37.21%60.39M-54.67%56.5M-52.24%73.14M27.70%93.94M-4.92%96.18M-1.53%124.65M
-Notes receivable -31.21%6.04M39.85%8.96M87.04%3.76M-96.40%318.63K210.13%8.78M8.92%6.41M-46.61%2.01M46.55%8.84M2.58%2.83M1,565.61%5.88M
-Accounts receivable 24.63%64.33M101.01%100.69M91.02%135.87M-46.34%45.66M-44.71%51.61M-57.82%50.09M-52.39%71.13M26.01%85.09M-5.13%93.35M-5.91%118.77M
Other receivables (including interest and dividends) 0.94%57.84M-6.27%63.56M-18.00%55.46M130.58%65.9M-28.94%57.31M-23.35%67.81M-22.76%67.64M-66.17%28.58M71.07%80.64M100.61%88.46M
-Other receivable 0.94%57.84M-----18.00%55.46M-----28.94%57.31M-----22.76%67.64M----71.07%80.64M----
Advance payment -12.65%34.84M-3.23%37.63M-68.32%28.1M57.94%37.39M79.09%39.88M24.77%38.89M315.00%88.7M-8.77%23.68M-27.63%22.27M-10.42%31.16M
Inventories -1.15%245.22M8.16%240.87M38.75%236.43M50.71%264.13M38.79%248.07M15.32%222.69M-13.88%170.4M-19.71%175.25M-18.98%178.74M-8.75%193.11M
Other current assets 133.24%6.23M-1.91%3.05M593.00%5.33M1,120.49%7.72M653.91%2.67M217.72%3.11M-44.34%768.88K-84.13%632.78K-95.09%354.14K-81.47%979.19K
Total current assets -11.15%515.22M0.09%569.05M-9.11%609.35M4.61%525.77M11.36%579.91M-4.90%568.52M-6.87%670.46M-29.43%502.58M-14.04%520.75M-6.13%597.79M
Non Current assets
Other equity investment -10.87%5.3M-10.87%5.3M-10.87%5.3M-3.91%5.95M-3.91%5.95M-3.91%5.95M-3.91%5.95M11.47%6.19M11.47%6.19M11.47%6.19M
Investment real estate -4.88%226.01M-4.88%226.01M-4.88%226.01M-8.25%237.61M-8.25%237.61M-8.25%237.61M-6.07%237.61M3.76%258.98M3.76%258.98M3.76%258.98M
Long-term equity investment -----------------------------66.36%4.63M-66.31%4.68M-66.17%4.73M
Fixed assets -1.81%847.79M-----5.53%841.67M----156.97%863.42M----169.49%890.94M----4.91%335.99M----
Fixed assets liquidation --27.9K------27.9K----------------------------
Constru in process 63.55%146.29M----144.37%145.62M-----86.95%89.44M-----90.96%59.59M----13.89%685.27M----
Productive biological assets --17.16K------------------------------------
Intangible assets -3.20%157.84M-4.36%158.06M-4.31%160.33M-17.36%161.08M-17.45%163.06M-17.42%165.26M-17.33%167.55M3.67%194.91M22.50%197.52M23.18%200.13M
Development expenditure 22.86%46.86M14.50%43.67M16.85%43.64M0.80%38.14M0.80%38.14M0.80%38.14M-1.29%37.35M16.51%37.83M16.51%37.83M16.85%37.83M
Goodwill 9.19%20.63M6.14%20.05M6.14%20.05M0.00%18.89M0.00%18.89M0.00%18.89M0.00%18.89M-15.25%18.89M-93.88%18.89M-93.88%18.89M
Long deferred expense -13.87%32.35M-1.96%38.03M-1.26%37.38M4.78%35.65M20.28%37.56M16.88%38.79M8.10%37.86M-5.10%34.02M-22.77%31.23M-14.12%33.19M
Deferred tax assets 17.97%58.04M-8.96%43.37M-11.70%42.3M48.82%43.78M83.35%49.2M70.55%47.64M84.71%47.9M12.01%29.42M-7.13%26.83M-13.13%27.93M
Other non current assets -52.19%29.61M-37.08%57.09M-70.32%33.95M-69.03%38.88M-53.27%61.93M-47.49%90.73M-30.56%114.37M-29.12%125.56M-30.12%132.52M3.40%172.76M
Total non current assets 0.36%1.57B-1.16%1.56B-3.82%1.56B-9.23%1.56B-9.84%1.57B-10.28%1.58B-6.95%1.62B2.13%1.72B-12.09%1.74B-8.24%1.76B
Total assets -2.76%2.09B-0.83%2.13B-5.37%2.17B-6.10%2.09B-4.94%2.15B-8.91%2.15B-6.93%2.29B-7.24%2.22B-12.54%2.26B-7.71%2.36B
Liabilities
Current liabilities
Short term loan 66.20%174.51M60.77%169.8M5.01%139.89M17.29%84M-12.15%105M-27.28%105.62M-10.29%133.22M-63.45%71.62M-53.94%119.52M-33.86%145.25M
Notes payable and accounts payable -27.92%75.56M9.11%63.82M35.92%78.02M48.21%99.85M25.35%104.83M-39.46%58.49M-48.90%57.4M-42.15%67.37M-39.33%83.63M-19.32%96.61M
-Notes payable -85.55%5.78M----------40M--40M--------------------
-Accounts payable 7.64%69.78M9.11%63.82M35.92%78.02M-11.17%59.85M-22.48%64.83M-39.46%58.49M-48.90%57.4M-42.15%67.37M-39.33%83.63M-19.32%96.61M
Contract liabilities 42.52%25.43M-39.57%14.42M-88.72%10.79M33.37%13.99M31.20%17.85M61.50%23.87M266.55%95.66M-3.43%10.49M-51.63%13.6M-46.31%14.78M
Advance receipts 797.87%240K48.01%12.3K-33.33%7.78K--21.15K--26.73K--8.31K--11.68K------------
Salaries payable -4.72%8.17M-18.50%8.66M0.16%11.09M-3.93%8.78M-1.37%8.58M25.59%10.62M12.27%11.07M12.65%9.14M-36.27%8.7M-35.04%8.46M
Taxs payable -34.08%9.85M80.74%24.81M28.85%32.2M12.40%16.71M-29.43%14.95M-17.24%13.73M-2.45%24.99M26.82%14.86M55.19%21.18M35.95%16.59M
Other payable (including interest and dividends) 23.64%74.72M0.40%70.18M-1.30%70.44M13.12%62.31M5.07%60.44M20.59%69.9M17.92%71.36M-19.35%55.08M-33.83%57.52M-27.53%57.97M
-Interest payable ----------------------640.69K----------------
-Other payable 23.64%74.72M-----1.30%70.44M----5.07%60.44M----17.92%71.36M-----26.19%57.52M----
Non current liabilities due within one year 8.94%75.94M-56.51%37.62M-65.65%36.77M-26.75%69.71M-29.38%69.71M-11.14%86.51M6.22%107.05M215.26%95.17M234.81%98.72M381.61%97.35M
Other current liabilities 38.12%3.19M-43.20%1.76M-63.05%1.38M32.89%1.81M30.78%2.31M61.40%3.1M207.04%3.74M-33.96%1.36M0.04%1.77M36.90%1.92M
Total current liabilities 16.67%447.63M5.17%391.09M-24.56%380.59M9.87%357.18M-5.18%383.69M-15.28%371.85M4.04%504.51M-26.73%325.1M-29.12%404.63M-11.10%438.93M
Current liabilities
Long term loan -12.91%267.06M-0.09%322.05M-5.21%324.98M-16.15%305.14M-1.08%306.64M-4.46%322.33M-0.20%342.85M-1.97%363.9M-21.62%310M-12.26%337.37M
Deferred tax liabilities -4.69%33.33M-2.15%34.04M-2.16%33.86M-15.56%35.15M-15.63%34.97M-15.70%34.79M-15.79%34.6M1.57%41.63M-2.19%41.45M-1.99%41.27M
Long term deferred income 3.14%51.13M-5.56%47.49M-5.54%48.18M-5.03%48.87M35.05%49.57M42.01%50.29M43.23%51M43.72%51.46M1.74%36.71M-2.72%35.41M
Total non current liabilities -10.14%351.52M-0.94%403.58M-5.00%407.01M-14.84%389.16M0.78%391.18M-1.61%407.4M1.96%428.45M1.09%456.99M-20.48%388.16M-15.68%414.05M
Total liabilities 3.13%799.15M1.98%794.66M-15.58%787.6M-4.57%746.34M-2.26%774.87M-8.64%779.25M3.07%932.96M-12.69%782.09M-25.14%792.79M-13.38%852.98M
Shareholders equity
Paid-in capital 0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M
Capital reserve funds 3.43%847.08M2.86%842.36M2.14%836.49M1.07%827.73M0.00%818.96M0.00%818.96M0.00%818.96M-0.12%818.96M-0.12%818.96M-0.12%818.96M
Surplus reserve funds 4.00%54.94M4.00%54.94M4.00%54.94M0.00%52.83M0.00%52.83M0.00%52.83M0.00%52.83M10.80%52.83M10.80%52.83M10.80%52.83M
Retained profit -258.03%-149.52M-123.08%-95.16M16.21%-48.66M-494.57%-78.53M-200.05%-41.76M-151.23%-42.66M-144.84%-58.07M-75.75%19.9M-36.79%41.74M-18.99%83.27M
Other composite income -0.92%51.98M-0.92%51.98M-0.92%51.98M-0.34%52.47M-0.34%52.47M-0.34%52.47M-0.34%52.47M0.92%52.65M0.92%52.65M0.92%52.65M
Shareholders equity without minority interests -5.85%1.25B-2.06%1.3B2.17%1.34B-6.44%1.3B-5.91%1.33B-8.65%1.33B-12.48%1.32B-3.96%1.39B-1.37%1.42B-1.01%1.46B
Minority interests -14.28%32.35M-15.06%32.44M-15.41%33.26M-21.33%36.83M-20.92%37.74M-21.45%38.19M-20.86%39.33M-5.02%46.81M-44.20%47.72M-50.97%48.61M
Total shareholder equity -6.09%1.29B-2.43%1.34B1.66%1.38B-6.93%1.34B-6.40%1.37B-9.06%1.37B-12.75%1.36B-4.00%1.44B-3.78%1.46B-4.16%1.51B
Total liabilityies and equity -2.76%2.09B-0.83%2.13B-5.37%2.17B-6.10%2.09B-4.94%2.15B-8.91%2.15B-6.93%2.29B-7.24%2.22B-12.54%2.26B-7.71%2.36B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data